These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9918266)

  • 1. The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials.
    Ortiz Z; Shea B; Garcia Dieguez M; Boers M; Tugwell P; Boonen A; Wells G
    J Rheumatol; 1999 Jan; 26(1):210-6. PubMed ID: 9918266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology.
    Wells G; Boers M; Shea B; Tugwell P; Westhovens R; Saurez-Almazor M; Buchbinder R
    J Rheumatol; 1999 Jan; 26(1):217-21. PubMed ID: 9918267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative responsiveness of generic and specific quality-of-life instruments.
    Wiebe S; Guyatt G; Weaver B; Matijevic S; Sidwell C
    J Clin Epidemiol; 2003 Jan; 56(1):52-60. PubMed ID: 12589870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
    Chen HH; Chen DY; Chen YM; Lai KL
    Clin Rheumatol; 2017 Jan; 36(1):133-142. PubMed ID: 27837342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability, validity and feasibility of quality of life instruments for adult patients with cancer undergoing chemotherapy: result from a systematic review.
    Yip WK; Mordiffi SZ; Ang E
    Int J Evid Based Healthc; 2012 Mar; 10(1):27-52. PubMed ID: 22405415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on outcome assessment in rheumatic disorders.
    Molenaar E; van der Heijde D; Boers M
    Curr Opin Rheumatol; 2000 Mar; 12(2):91-8. PubMed ID: 10751011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicidal behaviors in patients with rheumatic diseases: a narrative review.
    Calandre EP; Rico-Villademoros F; Slim M
    Rheumatol Int; 2018 Apr; 38(4):537-548. PubMed ID: 29264638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage indices in rheumatic diseases: A systematic review of the literature.
    Ferdowsi N; Stevens W; Baron M; Nikpour M
    Semin Arthritis Rheum; 2019 Aug; 49(1):27-34. PubMed ID: 30745021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.
    Choy EH; Smith C; Doré CJ; Scott DL
    Rheumatology (Oxford); 2005 Nov; 44(11):1414-21. PubMed ID: 16030080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which health-related quality-of-life outcome when planning randomized trials: disease-specific or generic, or both? A common factor model.
    Ades AE; Lu G; Madan JJ
    Value Health; 2013; 16(1):185-94. PubMed ID: 23337230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia.
    Pickard AS; Topfer LA; Feeny DH
    J Natl Cancer Inst Monogr; 2004; (33):102-25. PubMed ID: 15504922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic quality-of-life assessment in rheumatoid arthritis.
    Tugwell P; Idzerda L; Wells GA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S224-36. PubMed ID: 18095786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of endpoints in osteoporosis clinical trials--an update.
    Cranney A; Welch V; Tugwell P; Wells G; Adachi JD; McGowan J; Shea B
    J Rheumatol; 1999 Jan; 26(1):222-8. PubMed ID: 9918268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
    van der Heijde D; Calin A; Dougados M; Khan MA; van der Linden S; Bellamy N
    J Rheumatol; 1999 Apr; 26(4):951-4. PubMed ID: 10229426
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.